The Biology and Diagnosis of FAHN

Understanding the biology of Fatty Acid Hydroxylase-associated Neurodegeneration (FAHN) helps explain why your child is experiencing specific symptoms. At its core, FAHN is a disorder of how the brain builds and maintains its wiring ^[1].

The Biological Breakdown

Every person has two copies of the FA2H gene ^[2]. In children with FAHN, both copies have changes (pathogenic variants) that reduce or alter the function of the gene ^[1].

The FA2H gene provides instructions for making an enzyme called fatty acid 2-hydroxylase ^[3]. This enzyme has a very specific job: it adds a small chemical group (a hydroxyl group) to certain fats in the brain ^[4]. These specialized fats are crucial building blocks for myelin, the protective insulation that wraps around nerve fibers ^[5].

When this enzyme’s function is impaired:

• Myelin formation is disrupted: Without the right fats, the myelin cannot form the tight, compact layers needed to protect nerves ^[6].
• Communication breaks down: Nerve signals can no longer travel quickly or clearly ^[7].
• Nerve loss occurs: Over time, the lack of healthy myelin is thought to contribute to the loss of the nerve fibers themselves (axonal loss), which drives the physical symptoms of the disease ^[1].

Decoding the MRI: The “WHAT” Pattern

While you are not expected to be a radiologist, understanding the MRI report can help you advocate for your child. Doctors often look for a specific descriptive pattern in FAHN called WHAT. In one cohort of patients, at least three of these four features were present in about 85% of FA2H mutation carriers ^[1]:

1. W - White-matter changes: This refers to bright spots on certain MRI sequences (T2-weighted images) that show where myelin is missing or damaged ^[1][8].
2. H - Hypointensity of the globus pallidus: This is a technical way of saying these areas look “dark” on certain scans, which often indicates iron accumulation ^[1].
3. A - Atrophy (Pontocerebellar): This means “shrinking” of the pons and cerebellum, parts of the brain that control balance and coordination ^[1].
4. T - Thin corpus callosum: The corpus callosum is the bridge of nerves connecting the two sides of the brain. In FAHN, this bridge is often much thinner than normal ^[1][8].

Crucially, the WHAT pattern is supportive, not a strict diagnostic rule, and iron is not always present. In some studies, significant numbers of children with FAHN did not show visible iron buildup on their MRI, and one reported patient remained “iron-negative” even 18 years after symptoms began ^[8][9]. If your child’s report says “no iron detected,” it does not rule out FAHN ^[10]. Also, globus pallidus hypointensity requires specialized iron-sensitive MRI sequences (like SWI or T2*) to be properly assessed for iron.

Genetic Testing: The Definitive Answer

Confirmatory molecular testing, when interpreted with the clinical picture, provides the definitive diagnosis ^[11]. There are several types of tests used:

• Gene Panels: These look at a specific group of genes known to cause similar symptoms (like NBIAs or leukodystrophies) ^[12].
• Whole Exome Sequencing (WES): This looks at all the “coding” parts of every gene and is often more successful at finding rare variants ^[13].
• Deletion/Duplication Analysis (e.g., MLPA): Standard sequencing can sometimes miss large missing or extra chunks of DNA. If only one variant is found but the symptoms fit, doctors may use validated copy-number analysis to look for a second hidden change ^[14][15].

Interpreting Your Results

Your child’s report will use specific terms to describe the variants:

• Homozygous: The two gene copies carry the exact same variant, which usually reflects inheritance of that variant from both carrier parents ^[10].
• Compound Heterozygous: The child inherited two different changes in the same gene—one from the mother and one from the father (variants in trans) ^[16].

To be confident in the diagnosis, the laboratory should have classified the variants as Pathogenic or Likely Pathogenic ^[10][17]. A “Variant of Uncertain Significance” (VUS) is not diagnostic on its own and requires expert review to determine if it is truly the cause of the disease ^[17]. A negative gene panel or exome test also does not completely exclude the disorder if the clinical suspicion remains high.